ResearchSafe

RAD-140 (Testolone) (Testolone (RAD-140))

Category: Muscle Growth. Status: Investigational (not approved; banned in sport).

A potent selective androgen receptor modulator (SARM) studied for strong anabolic effects on muscle. It is not approved for human use, is banned in sport, and carries notable suppression and liver-stress concerns.

How it works

Acts as a strong, tissue-selective androgen receptor agonist in muscle and bone, driving anabolic signaling with a higher anabolic-to-androgenic ratio than testosterone in preclinical models.

Key facts

  • Molecular weight: 393.83 Da
  • Half-life: ~16-20 hours
  • Bioavailability: Oral
  • Storage: Keep cool, dry, and sealed; protect from light.

Dosing overview

  • Typical dose: Commonly cited 5-15 mg/day (research)
  • Frequency: Once daily
  • Duration: Commonly cited 6-10 week cycles
  • Route: Oral

Protocol notes

  • Once-daily oral dosing is typical.
  • Reported as more suppressive than Ostarine; users plan a recovery/PCT phase.
  • Regular bloodwork (testosterone, lipids, liver markers) is strongly advised.

Reported benefits

  • Strong lean muscle gains (research)
  • Increased strength
  • Studied originally for muscle wasting and breast cancer
  • Bone-supportive signaling

Possible side effects

  • Marked testosterone suppression
  • Liver enzyme elevation
  • Lowered HDL cholesterol
  • Aggression/mood changes
  • Potential hair shedding

Research

  • RAD-140 preclinical anabolic profile (2011): Showed potent, tissue-selective anabolic activity in muscle with reduced prostate effects in primates.

Compare RAD-140 (Testolone)

Research and educational reference only. Not medical advice.